文献
J-GLOBAL ID:201802212295151926
整理番号:18A0279372
オリジネイターインフリキシマブ(NOR SWITCH)による維持治療と比較したバイオシミラーCT P13へオリジネイターインフリキシマブからの切り替え:52週間の無作為化二重盲検,非劣性試験【Powered by NICT】
Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial
著者 (15件):
Jorgensen Kristin K
(Department of Gastroenterology, Akershus University Hospital, Lorenskog, Norway)
,
Olsen Inge C
(Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway)
,
Goll Guro L
(Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway)
,
Lorentzen Merete
(Department of Dermatology, Oslo University Hospital, Rikshospitalet, Oslo, Norway)
,
Bolstad Nils
(Department of Medical Biochemistry, Oslo University Hospital, Radiumhospitalet, Oslo, Norway)
,
Haavardsholm Espen A
(Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway)
,
Haavardsholm Espen A
(Faculty of Medicine, University of Oslo, Oslo, Norway)
,
Lundin Knut E A
(Department of Gastroenterology, Oslo University Hospital, Rikshospitalet, Oslo, Norway)
,
Lundin Knut E A
(Faculty of Medicine, University of Oslo, Oslo, Norway)
,
Lundin Knut E A
(Centre for Immune Regulation, University of Oslo, Oslo, Norway)
,
Mork Cato
(Institute of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway)
,
Jahnsen Jorgen
(Department of Gastroenterology, Akershus University Hospital, Lorenskog, Norway)
,
Jahnsen Jorgen
(Faculty of Medicine, University of Oslo, Oslo, Norway)
,
Kvien Tore K
(Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway)
,
Kvien Tore K
(Faculty of Medicine, University of Oslo, Oslo, Norway)
資料名:
Lancet
(Lancet)
巻:
389
号:
10086
ページ:
2304-2316
発行年:
2017年
JST資料番号:
B0673A
ISSN:
0140-6736
CODEN:
LANCA
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)